Healthcare utilization and costs in severely obese subjects before bariatric surgery

Obesity

Volumn 20, Issue 12, 2012, Pages 2412-2419

  Keating, Catherine L ^a   Moodie, Marj L ^a   Bulfone, Liliana ^a   Swinburn, Boyd A ^a   Stevenson, Christopher E ^b   Peeters, Anna ^b,c  

^a DEAKIN UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANESTHETIC AGENT; ANGIOTENSIN DERIVATIVE; ANTHELMINTIC AGENT; ANTI ACNE AGENT; ANTIANEMIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIFUNGAL AGENT; ANTIGOUT AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFLAMMATORY AGENT; ANTIPARKINSON AGENT; ANTIPROTOZOAL AGENT; ANTIPRURITIC AGENT; ANTIPSORIASIS AGENT; ANTIRHEUMATIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRONCHODILATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CENTRAL STIMULANT AGENT; CORTICOSTEROID; DIURETIC AGENT; EMOLLIENT AGENT; IMMUNOSUPPRESSIVE AGENT; MUSCLE RELAXANT AGENT; PERIPHERAL VASODILATING AGENT; UNINDEXED DRUG;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; AUSTRALIA; BARIATRIC SURGERY; CONSULTATION; DISEASE SEVERITY; FEMALE; GASTRIC BANDING; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SERVICE; OBESITY; OUTCOME ASSESSMENT; SEX; SLEEP DISORDERED BREATHING; STANDARDIZED INCIDENCE RATIO;

EID: 84870293728     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2012.124     Document Type: Article

References (28)

1. Freedman DS, Khan LK, Serdula MK, Galuska DA, Dietz WH. Trends and correlates of class 3 obesity in the United States from 1990 through 2000. JAMA 2002;288:1758-1761.
2. Walls HL, Wolfe R, Haby MM et al. Trends in BMI of urban Australian adults, 1980-2000. Public Health Nutr 2010;13:631-638.
3. Hensrud DD, Klein S. Extreme obesity: a new medical crisis in the United States. Mayo Clin Proc 2006;81:S5-10.
4. Must A, Spadano J, Coakley EH et al. The disease burden associated with overweight and obesity. JAMA 1999;282:1523-1529.
5. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994;17:961-969.
6. Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995;122:481-486.
7. Andreyeva T, Sturm R, Ringel JS. Moderate and severe obesity have large differences in health care costs. Obes Res 2004;12:1936-1943.
8. Arterburn DE, Maciejewski ML, Tsevat J. Impact of morbid obesity on medical expenditures in adults. Int J Obes (Lond) 2005;29:334-339.
9. Finkelstein EA, Ruhm CJ, Kosa KM. Economic causes and consequences of obesity. Annu Rev Public Health 2005;26:239-257.
10. Heithoff KA, Cuffel BJ, Kennedy S, Peters J. The association between body mass and health care expenditures. Clin Ther 1997;19:811-820.
11. Narbro K, Agren G, Jonsson E et al. Pharmaceutical costs in obese individuals: comparison with a randomly selected population sample and long-term changes after conventional and surgical treatment: the SOS intervention study. Arch Intern Med 2002;162:2061-2069.
12. Quesenberry CP Jr, Caan B, Jacobson A. Obesity, health services use, and health care costs among members of a health maintenance organization. Arch Intern Med 1998;158:466-472.
13. Wee CC, Phillips RS, Legedza AT et al. Health care expenditures associated with overweight and obesity among US adults: importance of age and race. Am J Public Health 2005;95:159-165.
14. Bhandari A, Wagner T. Self-reported utilization of health care services: improving measurement and accuracy. Med Care Res Rev 2006;63: 217-235.
15. Australian Department of Health and Ageing. Medicare Benefits Schedule online . http://www.mbsonline.gov.au/〉 Accessed 11 May 2011.
16. Australian Department of Health and Ageing. Pharmaceutical Benefits Schedule online . http://www.pbs.gov.au/pbs/home〉 Accessed 11 May 2011.
17. World Health Organisation. Collaborating Centre for Drug Statistics Methodology . Accessed 5 June 2011. http://www.whocc.no/〉
18. Armitage P, Berry G, Matthews JNS. Statistical Methods in Medical Research, 4th edn. Blackwell Science: Malden, MA, 2002.
19. Australian Productivity Commission. Private Hospitals in Australia. http://www.pc.gov.au/research/commissionresearch/privatehospitals〉 Accessed 29 April 2011.
20. Hawn MT, Bian J, Leeth RR et al. Impact of obesity on resource utilization for general surgical procedures. Ann Surg 2005;241:821-6; discussion 826.
21. Sturm R. Increases in clinically severe obesity in the United States, 1986-2000. Arch Intern Med 2003;163:2146-2148.
22. O'Brien PE, Dixon JB, Brown W et al. The laparoscopic adjustable gastric band (Lap-Band): a prospective study of medium-term effects on weight, health and quality of life. Obes Surg 2002;12:652-660.
23. Australian Department of Health and Ageing. Clinical practice guidelines for the management of overweight and obesity in adults . http://www.health. gov.au/internet/main/publishing.nsf/Content/obesityguidelines-guidelinesadults. htm Accessed 2 January 2011.
24. Haslam DW, James WP. Obesity. Lancet 2005;366:1197-1209.
25. Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med 1993;119: 655-660.
26. Howard NJ, Taylor AW, Gill TK, Chittelborough CR. Severe obesity: investigating the socio-demographics within the extremes of body mass index. Obesity Res Clin Prac 2008;2:51-59.
27. Fried M, Hainer V, Basdevant A et al. Inter-disciplinary European guidelines on surgery of severe obesity. Int J Obes (Lond) 2007;31:569-577.
28. Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr 1992;55:615S-619S.